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Abstract
Amphotericin B (AmB) is a popular drug frequently applied in the treatment of mycosis. Differential scanning calorimetry
(DSC), ultrasound absorption and monomolecular layer technique were applied to study the effect of AmB on organisation
of dipalmitoylphosphatidylcholine (DPPC) membranes. DSC-determined enthalpy of the main phase transition of DPPC
liposomes was found to be a sensitive parameter to monitor AmB^DPPC interaction. The enthalpy of the phase transition
decreases with the increase in molar fraction of AmB incorporated to membranes. The exceptionally sharp decrease in the
enthalpy of the transition was observed in the membranes containing 5^7 mol% AmB. Ultrasound absorption-monitored
main phase transition of DPPC is very broad under the presence of 5 mol% AmB showing destabilisation and disorganisation
of a membrane structure. These findings are discussed in comparison to monomolecular layer study of two-component
DPPC^AmB system. Analysis of the surface pressure^molecular area isotherms of compressing DPPC^AmB films at the air^
water interface shows pronounced increase in mean molecular area at AmB concentrations corresponding to those found to
destabilise DPPC membranes of liposomes. Disorganisation of lipid bilayers due to the presence of AmB in concentrations
below 10 mol% with respect to lipid is discussed in terms of toxicity and side effects of this drug. ß 1998 Elsevier Science
B.V. All rights reserved.
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1. Introduction
Amphotericin B (AmB) is the main antibiotic used
in patients with deep-seated mycotic infections. The
therapeutic usefulness of AmB and its clinical attrac-
tion is, however, limited because of severe side e¡ects
(see [1,2]). There are some hypotheses relating toxic-
ity of AmB to its stereochemical structure (see Fig. 1)
which is responsible for the formation of pores
across lipid membranes, which are able to a¡ect
physiological ion transport considerably [3]. Several
procedures have been elaborated to decrease the tox-
icity and harmful side e¡ects of AmB. One of the
approaches consists of preparation of pharmaceutics
containing AmB admixed to surfactants [4,5]. A
preparation of liposomal drug after admixture of
AmB to lipids has also been proposed [6]. In that
respect, the AmB^lipid interactions were recognised
0005-2736 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 9 8 ) 0 0 1 0 5 - 9
* Corresponding author. Fax: +48 (81) 537-6191;
E-mail : wieslaw@tytan.umcs.lublin.pl
BBAMEM 77424 4-8-98
Biochimica et Biophysica Acta 1373 (1998) 220^226
to be important and were the subject of several stud-
ies, including those based on calorimetry [6] and
monomolecular layer technique [7,8]. It appeared
that the composition of liposomes and concentration
of AmB in a lipid phase had a signi¢cant e¡ect on
drug toxicity [9,10]. Hamilton et al. [6] proposed that
these e¡ects might be related to the existence of AmB
oligomers forming phase-separated domains in the
lipid phase. Such an interpretation is consistent
with the ¢ndings that the presence of aggregated
AmB in a preparation used for pharmacological
treatment correlated with drug selective toxicity
[11]. Aggregated structures of AmB in a form of
hydrophobic pores in hydrated media may be formed
spontaneously as was shown in our previous work
[12]. In this report, we present some new results
which seem to indicate an additional molecular
mechanism operative at low molar fractions of
AmB in a lipid phase, which may be responsible
for the drug toxicity and its side e¡ects. According
to these results, the most pronounced e¡ect of AmB
in a¡ecting molecular organisation of DPPC mem-
branes is observable at low concentrations of AmB
below those promoting massive formation of oligo-
meric structures of the drug in a lipid phase. Such
¢ndings led us to revise the current concepts concern-
ing the molecular mechanism the of deleterious e¡ect
of AmB with respect to biomembranes.
2. Materials and methods
Dipalmitoylphosphatidylcholine (DPPC) and Am-
photericin B (AmB) were purchased from Sigma.
Liposome suspensions for the ultrasound absorption
measurements were prepared according to the gener-
al procedure described brie£y below. DPPC and
AmB stock solutions were prepared in ethanol and
2-propanol, respectively. Ethanol was applied as a
lipid solvent instead of the more frequently used
chloroform in order to assure homogenous mixing
of AmB and DPPC in a monomeric form of the
drug. In the case of AmB, the stock solution was
centrifuged at 15 000Ug in order to remove drug
which was not dissolved under such conditions and
the ¢nal concentration was evaluated from light ab-
sorption measurements at 408 nm on the basis of the
molar extinction coe⁄cient in 2-propanol (1.3U105
M31 cm31). The required amounts of lipid and AmB
were mixed and evaporated under stream of dry ni-
trogen to form a thin homogeneous ¢lm on a glass
tube. Residuals of organic solvents were removed in
a vacuum and 10 ml of a phosphate bu¡er (10 mM,
pH 8.0) was added to the tube containing a thin, dry
and homogeneous ¢lm of DPPC^AmB. Small unila-
mellar liposomes were formed via sonication of the
sample with ultrasonic disintegrator for 3 min at
45‡C, above the main phase transition temperature
of DPPC. After preparation, liposome suspension
was cooled down to the temperature of 25‡C and
centrifuged at 15 000Ug in order to remove large
particles of AmB eventually not incorporated to lip-
osomes. Not any residuals remaining as a pellet in
the concentration range studied were detected by vis-
ual inspection and by light absorption measurements
of 2-propanol added to centrifuge tubes after remov-
ing liposome suspension present as supernatant. On
the other hand, the possibility may not be excluded
that a certain small amount of AmB remained in a
liposome suspension in an aggregated form not
bound to the lipid phase. Spectral analysis of lipo-
some suspensions showed that such AmB fraction
may not exceed 1036 M. Which was considered not
to a¡ect an interpretation of the results of this study.
The ¢nal concentration of the lipid in water phase
was 1.5U1033 M. Liposomes for di¡erential scan-
ning calorimetric (DSC) measurements were pre-
pared following the same protocol except that the
sample volume was 100 Wl, sonication was performed
with the ultrasound bath and samples were not sub-
jected to centrifugation after sonication. Liposomes
were prepared directly before the measurements.
Measurements of ultrasound absorption in the fre-
quency range 1100^1400 kHz were carried out with
the home-built interferometer similar to that de-
scribed by Eggers and Funck [13]. The details con-
cerning experimental set-up and conditions of meas-
urements are described elsewhere [14]. Thermostatic
conditions were kept with the accuracy of þ 0.05‡C.
The measured excess of ultrasound absorption per
wavelength (vKWV) is theoretically analysed and ex-
plained elsewhere [13,15] and is generally accepted
to express the part of energy of ultrasound wave
consumed in perturbation of equilibrium of the
studied system. Calorimetric measurements were car-
ried out with a DSC model UNIPAN 605M. Lip-
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osome suspension was scanned versus pure bu¡er as
a reference. The scan rate was 0.5‡C per min. Mono-
molecular layers were formed at the air^water inter-
face in a 300 cm2 Te£on trough. Deionised double
distilled water distilled the third time in glass set-up
with the addition of KMnO4 was applied as a sub-
phase. DPPC and AmB to be deposited at the air^
water interface were dissolved in benzene/ethanol
(9:1, v/v) and 2-propanol/water (6:2, v/v), respec-
tively. Drops of DPPC and AmB solutions were de-
posited very gently at the interface to form a mono-
layer. Such a procedure was extremely important for
deposition of AmB in 2-propanol miscible with the
subphase. To form mixed, two-component DPPC^
AmB monolayers, DPPC was deposited as a ¢rst
component and, after the 15 min required for evap-
oration of benzene AmB, was deposited at several
di¡erent places at the air^water interface in order
to obtain homogeneous monolayer. Such a method
of a deposition of monolayer of AmB yields mono-
meric organisation of the drug at the air^water inter-
face before ¢lm compression. In this respect, the ini-
tial molecular area in monolayers before
compression was as large as 200 Aî 2. Monolayers
were compressed with a speed of 30 cm2 per min.
Surface pressure was monitored by NIMA-Wilhelmi
plate tensiometer. Monolayer compression and data
acquisition were controlled on-line by a personal
computer. Monolayer formation and compression
was carried out at 25‡C.
3. Results and discussion
Several experimental techniques may be applied to
detect the main thermotropic phase transition of
phosphatidylcholines including NMR [16], EPR
[17], DSC [18] and also ultrasound absorption [19].
The main phase transition of phosphatidylcholine
membranes (PL0^LK) sometimes called ‘melting’ con-
Fig. 1. Chemical structure of amphotericin B and schematic
representation of molecular dimensions corresponding to this
structure.
Fig. 2. (A) Original traces of DSC scanning of DPPC liposomes
containing di¡erent molar percentage of AmB, indicated. (B)
Enthalpy of the main phase transition of DPPC liposomes de-
picted versus concentration of AmB incorporated into the mem-
branes. Experimental points were obtained by integration of
DSC traces presented in (A).
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sists of a cooperative increase in the rate of trans-
gauche isomerisation of acyl chains of lipid molecules
forming hydrophobic core of a lipid bilayer. Going
through the phase transition results in abrupt
changes of several physical parameters of a mem-
brane, like the membrane £uidity directly related to
Fig. 3. Ultrasound absorption (vKWV) versus incubation temperature (T) of DPPC liposomes (U) and DPPC liposomes containing dif-
ferent concentration of AmB (a) indicated in each panel (A^F).
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the order of acyl chains. Fig. 2 presents the phase
transition of DPPC membranes containing di¡erent
amount of incorporated AmB, as analysed by means
of DSC. The same transition monitored by means of
ultrasound absorption technique is presented in Fig.
3. In most cases, additives to a membrane reduce the
order within liquid crystalline lipid structures de-
creasing cooperativity and enthalpy of phase transi-
tion [17,20]. As may be predicted, the gradual in-
crease in concentration of AmB in DPPC
membranes results in a decrease in the enthalpy of
the phase transition. This may be directly observed
from the DSC traces (enthalpy of a phase transition
being proportional to the surface of DSC peak). The
dependence of enthalpy of DPPC phase transition on
AmB content is depicted in Fig. 2B. As may be no-
ticed from this dependency, a pronounced decrease
in enthalpy accompanies the AmB concentrations
close to 5 mol%. The DSC-monitored energy uptake
by the DPPC membranes containing 5 mol% AmB is
very weak and broad compared to the typical DPPC
calorimetric signal characteristic of a phase transi-
tion. Ultrasound absorption measurements of the
sample of the same composition (Fig. 3C) clearly
show a¡ected temperature pro¢le of ultrasound en-
ergy uptake representing cooperative relaxation proc-
esses related directly to a molecular motion of lipid
Fig. 5. Surface pressure^molecular area isotherms of the com-
pression of two-component monomolecular layers formed with
DPPC and AmB. Composition of monolayers is presented.
Fig. 4. Surface pressure^molecular area isotherms of compres-
sion of monocomponent monomolecular layers formed with
DPPC (A) and AmB (B). The straight lines interpolated to the
linear parts of isotherms are indicated along with the corre-
sponding molecular areas.
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molecules. Such a result is a further indication of
disorganisation of the DPPC membrane structure
brought about by low-concentrated AmB. This e¡ect
was further studied by means of monomolecular
layer technique. Fig. 4 presents surface pressure^mo-
lecular area isotherms of compressing pure DPPC
and AmB monomolecular ¢lms. The speci¢c molec-
ular area of DPPC, evaluated by the method of ex-
trapolation of the linear part of the isotherm directly
preceding the monolayer collapse to the zero surface
pressure (47 Aî 2, see straight lines in Fig. 4), well
corresponds to the molecular area of phosphatidyl-
cholines at temperatures below the phase transition
[21]. Two distinct phases of the AmB monomolecular
layer compression are clearly visible from the iso-
therm presented in Fig. 4. Such a shape of the iso-
therm is very close to those reported previously for
AmB in a single component monolayer [7] and indi-
cates monomeric organisation of AmB at the air^
water interface before compressing. The isotherm re-
£ects two di¡erent orientations of AmB at the air^
water interface in which the drug occupies a mean
molecular area 145 and 36 Aî 2 (as deduced by the
isotherm extrapolation to the zero surface pressure
as in the case of DPPC explained above). These
mean molecular areas directly correspond to such
orientations of AmB at the air^water interface where
the molecule contacts subphase by its hydrophilic
side determined by the OH groups (6U24 Aî ) or by
the sugar ring and the COOH groups forming a spe-
ci¢c polar head (6U7 Aî ). Fig. 5 presents exemplary
isotherms of compressing two-component DPPC^
AmB monolayers at the air^water interface. Mean
molecular areas in two-component monolayers are
presented in Fig. 6 versus molar percentage of
AmB. As can be seen, the mean molecular areas in
two-component monolayers are always higher than
the corresponding areas of pure components. This
e¡ect is exceptionally high in the low AmB concen-
tration region (below 10 mol%). However, such an
e¡ect was not observed by Lance et al. [8] under
similar conditions, most probably due to the di¡er-
ences in solvents and in the technique of a monolayer
deposition. On the other hand, a similar e¡ect of a
decrease in enthalpy of the main phase transition
corresponding to 25 mol% AmB was observed in
multilamellar small vesicles formed with another lip-
id (DMPC) [6]. The molecular areas, higher than
expected on the basis of the additivity rule (repre-
sented by the straight line in Fig. 6), may be ex-
plained in terms of an empty space in the monolayer
due to AmB pores. This over-additivity is observed
in the region of high concentrations of AmB, in
which formation of pore-like aggregated structures
is very likely. Pores formed in a hydrophobic envi-
ronment are organised in such a way that they cover
inside polar OH groups and in consequence occupy a
higher area than all molecules involved in the forma-
tion of such a structure. A rough estimate for 90
mol% AmB at which the mean molecular area is
larger by ca. 49 Aî 2 leads to a model of AmB pore
formed by six molecules and a pore internal radius of
6.1 Aî . Such an estimate is close to a model of hydro-
phobic pore formed by 6 AmB molecules (a radius of
6.8 Aî , [12]). The most striking e¡ect is, however, the
exceptionally high over-additivity corresponding to
the low concentrations of AmB in a lipid phase.
Such an e¡ect may be explained in terms of a very
strong repulsive hydrophobic interactions between
polar groups of AmB located at one side of the mol-
ecule (see Fig. 1) and acyl chains of DPPC. Most
probably, such an e¡ect, distinctly demonstrated in
the mixed AmB^DPPC monolayers, is responsible
for the disorganisation of the structure of lipid bi-
layer pronounced in thermotropic phenomena.
As it follows from the experiments analysed above,
AmB present in lipid membranes at low concentra-
Fig. 6. Molecular area in a two-component monolayers versus
molar percentage of AmB. Each point represents mean from
three to ¢ve experiments. Error bars correspond to standard de-
viation. Molecular area values were evaluated on the basis of
extrapolation to the zero surface pressure lines ¢tted to the ¢nal
linear part of an isotherm corresponding to monolayer com-
pression preceding collapse (see Fig. 4).
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tions, below those promoting its aggregation in lipid
phase, strongly a¡ects membrane properties. It is
very probable that just this e¡ect is responsible for
very strong toxicity and severe side e¡ects of this
drug. In this respect, it is worth mentioning that 5
mol% AmB in 7:3 DMPC/DMPG sonicated lipo-
somes was found to be exceptionally toxic to mice
[9].
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